Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity

Abstract

These studies identify a novel mechanism responsible for ILT4-mediated immune suppression in the tumor microenvironment, and prove a novel concept of ILT4 as a critical checkpoint molecule for tumor immunotherapy.